Clinical Trial Search

Primary: Mortality, Heart Failure-related Urgent Care Visits, or Significant Increase in Left Ventricular End Systolic Volume Index (LVESVI) — 160; 191; 93; 136 participants…

Primary: Total Mortality — 307; 305 Participants — p=0.3492

Primary: Freedom From Any Atrial Arrhythmias — 24; 23 Participants — p=.83

Primary: Number of Patients With Reduction ≥ 15% in Left Ventricular End-systolic Volume (LVESV) — 5; 6 Participants — p=1.00

Primary: Comparison of Change in Echocardiographic Parameters LV Dimension at End-diastole, LV Dimension at End-systole, and Tricuspid Annular Plane Systolic Excursion (cm) From…

Primary: Combined Endpoint Defined as First Occurrence Among the Following Events 1)Syncope Episode of Any Origin; 2)Presyncopal Episode With Documented Cardioinhibitory Origin…

Primary: Slow Ventricular Tachycardia Episodes Devices Detected (Between 120-150 Bpm and > 30sec) Atrial Fibrillation (AF) Episodes Devices Detected (> 30 Sec) — 3778; 112; 68…

Primary: Device or Procedure Related AV Block Persistent Through Discharge From Hospital. — 0; 0 participants

Primary: Procedure-related Complication-free Rate — 92.7; 98.2 percentage of subjects

Primary: Atrial Ventricular Pacing Synchrony Success During Rest — 0; 38; 0; 2 Participants — p=<0.001

Primary: Aortic Velocity Time Integral (VTI) — 22.4; 21.7; 19.4; 18.1 cm

Primary: Efficacy of Anti Tachycardia Pacing (ATP) Therapy (Burst, 8 Pulses, 88 %, 1 Sequence) to Terminate All Types of Ventricular Tachycardia. — 64.7; 68.2 Percent of VT…

Primary: Number of Patients With Improved Clinical Composite Score — 86; 45 Participants — p=0.001

Primary: Change in Left Ventricular Ejection Fraction From Baseline to 2 Years (Intent to Treat Cohort). — -2.29; -3.43 percentage — p=0.4347

Primary: Percent of Patients Free From AF and Off Class I and III Anti-arrhythmic Drugs as Determined by Holter Monitoring at 6 Months. — 74 percentage of subjects

Primary: LVEF — 64.22; 63.14; 59.96 % LVEF — p=0.1734

Primary: Real-time Documentation of Pulmonary Vein Disconnection — 125 number of PVs disconnected in realtime

Primary: Unplanned Hospital Admissions for Cardiac Reasons OR Death of Cardiovascular Causes OR Progression to Chronic Atrial Fibrillation — 43; 44 participants

Primary: Number of Patients With Complete Sensory Block — 91; 79 percentage of participants — p=<0.01

Primary: Left Ventricular End-systolic Volume (LVESV) — -15; -19; -21 ml — p=.66

Primary: Pivotal Main Phase Modified Intent-To-Treat (mITT) Analysis Set: Number of Participants With Primary Adverse Events (PAEs) — 8 Participants

Primary: For the Primary Endpoint the Reduction of Ventricular Therapies (ATP and Shocks) Delivered for Treating Fast Spontaneous Arrhythmia Episodes Was Measured. — 67.1; 41.9…

Primary: Number of Participants With Transient Ischemic Attack — 6; 22 participants — p=0.001

Primary: Changes in Left Ventricular Mass Index — -1; -9; -6; -14 g/m^2

Primary: Number of Participants With Successful Balloon Occlusion of Superior Vena Cava — 18; 5 Participants

Primary: Percentage of Subjects Classified as "Not Worsened" for Changes in the Minnesota Living With Heart Failure Questionnaire and Six-minute Walk Distance Between Periods of…

Primary: Number of Perioperative Complications Associated With AtriClip Placement — 0 perioperative complications reported

Primary: Change in Pre- and Post-atenolol Ventricular Rate Response After 5 Minutes of Exercise — -10; -13 beats per minute

Primary: Chronic Effectiveness (Through 6 Months) of the Freezor Xtra Catheter for the Treatment of AVNRT Using an Endocardial Approach. — 368; 29 Participants — p=<0.0001

Primary: Total Narcotic Dose in Milligram Morphine Equivalents (MME) Per Kilogram — 0.035; 0.008 MME per kg